Pulike Biological Engineering, Inc. (SHA:603566)

SHA:603566 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,060	1,090	1,043	1,253	1,230	1,099
Revenue Growth	-2.32%	4.54%	-16.77%	1.84%	11.97%	18.32%
Gross Profit Gross Profit Growth	622.98	652.53	636.93	764.3	770.33	718.62
Operating Income Operating Income Growth	154.76	178.73	107.19	170.89	175.86	222.11
Net Income Net Income Growth	172.82	184.99	92.81	174.52	167.82	244.14
Earnings Per Share EPS Growth	0.50	0.54	0.27	0.50	0.52	0.78
EPS Growth	44.38%	100.00%	-46.00%	-3.85%	-33.33%	8.33%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025
Period Ending	Mar 31, 2026	Dec 31, 2025
Pig Vaccine Pig Vaccine Growth	243.86	263.11
Poultry Vaccines and Antibodies Poultry Vaccines and Antibodies Growth	476.02	485.23
Vaccines for Ruminants Vaccines for Ruminants Growth	9.33	6.38
Pets Pets Growth	15.34	16.09
Chemical Chemical Growth	255.62	253.71
Functional Health Products, Etc. Functional Health Products, Etc. Growth	22.62	24.65
Technology Licensing or Transfer Income Technology Licensing or Transfer Income Growth	26.07	27.78
Total Total Growth	1,049	1,077

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	754.34	773.16	685.59	724.79	973.01	243.83
Total Debt Total Debt Growth	27.24	27.23	1.26	2.05	9.69	-
Net Cash (Debt) Net Cash Growth	727.1	745.92	684.33	722.74	963.32	243.83
Net Cash Growth	0.84%	9.00%	-5.31%	-24.97%	295.08%	-53.03%
Net Cash Per Share Net Cash Per Share Growth	2.11	2.18	1.99	2.07	2.98	0.78

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	272.92	356.34	268.79	282.78	228.36	212.53
Capital Expenditures CapEx Growth	-72.57	-75.04	-121.06	-304.98	-357.16	-317.54
Free Cash Flow Free Cash Flow Growth	200.36	281.3	147.73	-22.2	-128.8	-105.01
Free Cash Flow Growth	-19.03%	90.42%	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	58.74%	59.87%	61.09%	61.01%	62.63%	65.41%
Operating Margin	14.59%	16.40%	10.28%	13.64%	14.30%	20.22%
Pretax Margin	17.93%	19.02%	9.47%	15.54%	14.45%	25.87%
Profit Margin	16.30%	16.97%	8.90%	13.93%	13.64%	22.22%
FCF Margin	18.89%	25.81%	14.17%	-1.77%	-10.47%	-9.56%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.600	0.600	0.400	0.700	0.350	0.200
Dividend Per Share Growth	50.00%	50.00%	-42.86%	100.00%	75.00%	-60.00%
Dividend Yield	5.72%	5.02%	3.40%	3.44%	1.47%	1.04%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	20.79	22.97	47.01	44.91	56.42	28.48
Forward PE	20.84	20.38	19.73	27.90	35.98	21.72
P/FCF Ratio	17.78	15.11	29.53	-	-	-
PS Ratio	3.36	3.90	4.18	6.26	7.70	6.33

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error